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Alternating hemiplegia of childhood is a rare disorder caused by de novo mutations in the ATP1A3 gene, expressed in neurons and
cardiomyocytes. As affected individuals may survive into adulthood, we use the term ‘alternating hemiplegia’. The disorder is
characterized by early-onset, recurrent, often alternating, hemiplegic episodes; seizures and non-paroxysmal neurological features
also occur. Dysautonomia may occur during hemiplegia or in isolation. Premature mortality can occur in this patient group and is
not fully explained. Preventable cardiorespiratory arrest from underlying cardiac dysrhythmia may be a cause. We analysed ECG
recordings of 52 patients with alternating hemiplegia from nine countries: all had whole-exome, whole-genome, or direct Sanger
sequencing of ATP1A3. Data on autonomic dysfunction, cardiac symptoms, medication, and family history of cardiac disease or
sudden death were collected. All had 12-lead electrocardiogram recordings available for cardiac axis, cardiac interval, repolariza-
tion pattern, and J-point analysis. Where available, historical and prolonged single-lead electrocardiogram recordings during
electrocardiogram-videotelemetry were analysed. Half the cohort (26/52) had resting 12-lead electrocardiogram abnormalities:
25/26 had repolarization (T wave) abnormalities. These abnormalities were signiﬁcantly more common in people with alternating
hemiplegia than in an age-matched disease control group of 52 people with epilepsy. The average corrected QT interval was
signiﬁcantly shorter in people with alternating hemiplegia than in the disease control group. J wave or J-point changes were seen in
six people with alternating hemiplegia. Over half the affected cohort (28/52) had intraventricular conduction delay, or incomplete
right bundle branch block, a much higher proportion than in the normal population or disease control cohort (P = 0.0164).
Abnormalities in alternating hemiplegia were more common in those 516 years old, compared with those 516 (P = 0.0095),
even with a speciﬁc mutation (p.D801N; P = 0.045). Dynamic, beat-to-beat or electrocardiogram-to-electrocardiogram, changes
were noted, suggesting the prevalence of abnormalities was underestimated. Electrocardiogram changes occurred independently of
seizures or plegic episodes. Electrocardiogram abnormalities are common in alternating hemiplegia, have characteristics reﬂecting
those of inherited cardiac channelopathies and most likely amount to impaired repolarization reserve. The dynamic electrocardio-
gram and neurological features point to periodic systemic decompensation in ATP1A3-expressing organs. Cardiac dysfunction may
account for some of the unexplained premature mortality of alternating hemiplegia. Systematic cardiac investigation is warranted
in alternating hemiplegia of childhood, as cardiac arrhythmic morbidity and mortality are potentially preventable.
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Introduction
Alternating hemiplegia of childhood (OMIM #104290) is a
rare neurodevelopmental disorder with onset before the age
of 18 months and prevalence estimated at 1:1 000 000 to
1:100 000 (Neville and Ninan, 2007; Gilissen et al., 2012).
Affected children typically survive to adulthood, and we
use the label ‘alternating hemiplegia’. Pathogenic muta-
tions, almost always de novo, in the ATP1A3 gene,
encoding the catalytic alpha-3 subunit of the Na+ /K+ -
ATPase transporter protein, are the cause in 80% of
cases (Heinzen et al., 2012; Rosewich et al., 2012; Ishii
et al., 2013). No other cause is known.
Alternating hemiplegia is characterized by recurrent tran-
sient plegic or paretic attacks, affecting alternate or both
sides of the body, dystonic posturing, and oculomotor dys-
function (Bourgeois et al., 1993; Aicardi et al., 1995;
Panagiotakaki et al., 2010). Seizures are common, as are
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non-paroxysmal features including: dystonia, choreoatheto-
sis, ataxia, pyramidal signs, developmental delay and vary-
ing degrees of intellectual disability. Dysautonomia,
manifesting as dyspnoea, stridor, apnoea, pallor, fever,
and altered heart rate, is frequently described during
plegic episodes. Occasionally, autonomic dysfunction can
occur in isolation (Panagiotakaki et al., 2010). Recently,
asystole associated with new-onset episodes of collapse
with loss of consciousness, cyanosis and respiratory arrest
was reported in a patient with genetically-conﬁrmed alter-
nating hemiplegia, beneﬁtting from implantation of a per-
manent pacemaker (Novy et al., 2014).
Cardiac channelopathies, such as long QT syndrome,
Brugada syndrome, and catecholaminergic polymorphic
ventricular tachycardia, are associated with an increased
risk of malignant arrhythmias and sudden cardiac death
(Wilde et al., 2013). Most of the causative genes are ex-
pressed in a number of tissues, and neuromuscular mani-
festations are increasingly recognized (Abriel et al., 2013).
Some neuronal channelopathies, such as the multisystem
disorder Andersen-Tawil syndrome, associated with muta-
tions in the KCNJ2 gene, which is expressed in the brain
and heart, can also cause long QT syndrome (type 7;
OMIM #170390), increasing the risk of sudden cardiac
death; these patients are routinely kept under cardiac sur-
veillance. Patients with Dravet syndrome (OMIM #607208)
also have an elevated risk of premature mortality, ascribed
largely to sudden unexpected death in epilepsy (SUDEP)
(Hindocha et al., 2008; Genton et al., 2011). Some individ-
uals with Dravet syndrome exhibit reduced heart rate vari-
ability; ECG recordings may show increased P-wave and
QT dispersion, possibly contributing to mechanisms of
sudden death in Dravet syndrome (Delogu et al., 2011;
Ergul et al., 2013). Other syndromes with mutations in
ion-channel genes expressed in the brain and the heart,
termed ‘cardiocerebral channelopathies’ have features
related to both organs and may also cause sudden death
(Heron et al., 2010; Parisi et al., 2013).
Other than altered heart rate and a single report of asys-
tole, cardiac abnormalities have not been extensively
described in alternating hemiplegia, but sudden unex-
plained death has been reported (Panagiotakaki et al.,
2010; Novy et al., 2014). ATP1A3 is known to be ex-
pressed in the human and rat heart (Zahler et al., 1993;
Aye et al., 2010). We hypothesized that important electro-
cardiographic abnormalities are present in alternating
hemiplegia.
Materials and methods
Participants
This research was approved by local ethics committees of the
participating centres: The National Hospital for Neurology
and Neurosurgery UK; Great Ormond Street Hospital for
Children UK; Hospital Sant Joan de De´u Barcelona, Spain;
Istituto Giannina Gaslini, University of Genoa, Italy;
University Medical Center Go¨ttingen, Germany; C.Besta
Neurological Institute Milan, Italy; IRCCS E.Medea, Italy;
Duke University Medical Center, Durham, USA; The
Hospital for Sick Children and University of Toronto,
Toronto, Canada; Royal Children’s Hospital Melbourne,
Australia; Hoˆpital Pitie´-Salpeˆtrie`re, Paris, France; and
Neuropediatric Department, Hospital Maria Pia do Centro
Hospitalar do Porto, Portugal.
Informed consent was obtained from patients or their par-
ents, or legal guardians in the case of minors or those with
intellectual disability.
Participants were recruited through the International
Alternating Hemiplegia of Childhood Research Consortium
(IAHCRC), and the European Network for Research on
Alternating Hemiplegia (ENRAH), or personal communication
with collaborators, from nine countries. A total of 69 patients
meeting the clinical diagnostic criteria for typical alternating
hemiplegia were identiﬁed: 52 were suitable for inclusion
(Aicardi et al., 1995; Panagiotakaki et al., 2010). Patients
were excluded if they could not be consented or DNA could
not be obtained for ATP1A3 testing if previous mutation ana-
lysis had not been undertaken (Fig. 1), or an ECG recording
was unavailable.
We collected 52 fully anonymized ECGs from disease con-
trols, all of whom had epilepsy, and ranged in age from
1 month to 36 years. Demographics and details on ECG ﬁnd-
ings, epilepsy and treatments for the disease controls are pro-
vided in Supplementary Table 2.
Procedures
Clinical data about alternating hemiplegia (age of onset of
symptoms, presence of paroxysmal and non-paroxysmal fea-
tures, seizures, and dysautonomia), cardiac comorbidities,
medication use at the time of ECG recordings, and family
history of cardiac disease and sudden cardiac or unexplained
death were collected by collaborating physicians, and subse-
quently analysed.
Patients data from previously published studies were ana-
lysed by whole-exome or whole-genome sequencing according
to published, or local, protocols (Supplementary material)
(Heinzen et al., 2012; Rosewich et al., 2014). Direct Sanger
sequencing of ATP1A3 was undertaken in cases where muta-
tion status was unknown (Supplementary material). De novo
mutation status was evaluated by Sanger sequencing where
parental DNA was available; where unavailable, pathogenicity
was declared if the mutation was previously reported as de
novo in another patient. Cases where no mutation in
ATP1A3 was identiﬁed were included if they met the clinical
diagnostic criteria for alternating hemiplegia.
Original ECG records were scanned, collected and reviewed
centrally. For one UK patient, only serial historical ECGs were
available. Five patients had serial 12-lead ECGs available (four
had two ECGs, and one patient had three). All 12-lead ECGs
were recorded at a paper speed of 25 mm/s and amplitude of
10 mm/mV, and evaluated independently by three cardiologists
with expertise in cardiac electrophysiological disease, sudden
cardiac death and inherited cardiac disease (P.D.L., E.R.B.,
J.P.K.). Abnormal repolarization was deﬁned by the presence
of abnormal T wave morphology (ﬂattened or biphasic T
waves; biﬁd or notched T waves) or T wave inversion in
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two or more of the following leads: I, aVL and V4–V6 (lateral
repolarization abnormalities); II, III and aVF (inferior repolar-
ization abnormalities); and V1–V3 in patients aged 514 years
(anterior repolarization abnormalities); repolarization abnorm-
alities of this type are seen in 2% of healthy adults
(Rautaharju et al., 2009). The corrected QT interval was cal-
culated from lead II using Bazett’s formula (Bazett 1920); its
normal range is 360–460 ms (Priori et al., 2013); J-point ele-
vation and early repolarization were deﬁned as previously
described (Junttila et al., 2012), and are seen in 1–5% of
healthy individuals (Klatsky et al., 2003). Right bundle
branch block (complete and incomplete) and intraventricular
conduction delays (IVCDs) were deﬁned according to estab-
lished criteria (Surawicz et al., 2009). Isolated IVCD was con-
sidered normal in the absence of additional ECG
abnormalities, as it is seen in up to 5% of the normal
population (Chiu et al., 2008; Bussink et al., 2013). Isolated
right bundle branch block is seen in 2–4% of healthy individ-
uals (Bussink et al., 2013). Four patients (Patients 1, 37, 41
and 50; Tables 1 and 3) also had EEG-videotelemetry record-
ing (25–98 h), which included single-lead ECG (modiﬁed V1).
Data from the previously-reported patient (Patient 1) were re-
evaluated, given the novel ﬁndings from this study (Novy
et al., 2014).
Statistical analyses
Age-related differences in ECG abnormalities were calculated
using Fisher’s exact test, and differences in mean corrected QT
interval (QTc) between groups using the unpaired t-test. All
analyses were performed using the Statistical Package for
Social Sciences Software programme (IBM SPSS Statistics,
Version 22.0., IBM Corp). A Bonferroni correction was
applied where appropriate.
Results
Demographics
We analysed ECG data of 52 patients with alternating
hemiplegia, from nine countries: Spain (n = 14); UK
(n = 13); Italy (n = 7); Germany (n = 7); USA (n = 6);
Canada (n = 2); Australia (n = 1); France (n = 1); and
Portugal (n = 1). Twenty patients were aged 16 years or
over; 32 patients were under 16; 26 were female,
26 male (see Table 1). There was no signiﬁcant difference
in mean age between people with alternating hemiplegia
69 patients fulfilling diagnostic criteria for AH 
52 patients has ATP1A3 sequencing either by: 
1. Whole-exome or whole genome sequencing 
(previously published) 
2. Targeted next-generation gene sequencing 
3. Direct ATP1A3 Sanger sequencing 
17 patients excluded: 
• 1 patient with atypical AH history and no mutation in  
ATP1A3
• 16 patients with typical AHC could not be contacted for 
consent or had no ECG for review 
47 ATP1A3
mutations 
5 patients with no 
mutations in 
ATP1A3
52 patients for ECG review: 
• 52 12 lead-ECG at rest 
• 4 patients had prolonged modified lead V1 
recording on 25-98 hour EEG videotelemetry 
• 5 patients had serial ECG recordings 
• 1 patient had implantable cardiac loop recording 
(Novy et al. 2014).  
Figure 1 Study profile of patients recruited into study of ECG characteristics in patients with alternating hemiplegia.
AH = alternating hemiplegia; AHC = alternating hemiplegia of childhood.
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(173.8 months) and the disease controls (176.3 months)
(paired t-test, two-tailed, P = 0.166).
Molecular genetics
Forty-seven patients had a conﬁrmed missense mutation in
ATP1A3 identiﬁed either through previous whole-exome
sequencing (Heinzen et al., 2012; Rosewich et al., 2014),
or sequencing in this study (Table 2). The most frequent
mutation observed was c.2401G4A; p.D801N (n = 19;
36.5%) followed by c.2443G4A; p.E815K (n = 9;
17.3%), in keeping with previous reports (Heinzen et al.,
2012; E. Panagiotakaki, personal communication).
Mutations c.2443G4A, p.S772R; c.2411C4T, T804I;
c.1010T4G, L337R; and c.2781C4T, p.C927W have
recently been reported (E. Panagiotakaki, personal commu-
nication). One patient (Patient 37) had a 3-bp deletion. No
mutation in ATP1A3 was found in ﬁve patients after tar-
geted next-generation gene sequencing, whole-exome or
genome sequencing.
Clinical autonomic and cardiac
features in patients with alternating
hemiplegia
Autonomic features were reported in 32 patients (62%)
during plegic episodes (Table 1). Altered heart rate and
apnoeic episodes were reported by the carers of Patient 2,
and tachycardia and altered body temperature was docu-
mented in the medical records of Patient 49. Three patients
reported at least one episode of palpitation in isolation,
without syncope. One subject (Patient 1) started experien-
cing episodes of loss of consciousness with respiratory
arrest at the age of 21 years (Novy et al., 2014). Her rou-
tine 12-lead ECG recording was normal. She underwent
implantation of a cardiac loop recorder, which documented
three episodes of asystole longer than 3 s over a period of 4
months: a cardiac pacemaker was implanted. She had had
EEG-videotelemetry prior to pacemaker implantation. The
single-lead ECG that was part of the telemetry showed
sinus rhythm throughout, with no arrhythmias or changes
in QRS, J-point or T wave morphology.
Electrocardiographic features in
disease controls
Repolarization abnormalities were seen in 5/52 disease con-
trols, isolated to inferior leads in one, inferolateral in one
and widespread in three. Isolated anterior, lateral or infero-
anterior changes were not seen. IVCD was noted in 9/52
(17.3%), and incomplete right bundle branch block in sep-
arate 6/52 (11.5%) disease controls. Early repolarization
was seen in 3/52 (5.8%), whereas none had J-wave
changes, or IVCD/right bundle branch block in combin-
ation with pathological ECG ﬁndings. Data from these dis-
ease controls are provided in Supplementary Table 1.
Electrocardiographic features in
patients with alternating hemiplegia
Table 3 shows the ECG features of the study population.
Overall, ECG records were abnormal in 28 cases, with the
resting 12-lead ECG abnormal in 26 patients (50%). Some
changes were subtle. Seven of 52 (13.5%) disease control
ECGs were deemed abnormal using the same criteria, sig-
niﬁcantly fewer than the alternating hemiplegia group
(Fisher’s exact test, two-tailed, P = 0.0001).
Repolarization abnormalities were present in 25 patients
(48.1%). The prevalence of repolarization abnormalities in
the alternating hemiplegia cases was signiﬁcantly higher
than in the disease control group (25/52 versus 5/52 re-
spectively; Fisher’s exact test, two-tailed, P5 0.0001). Co-
existing ECG abnormalities included IVCD (n = 10,
19.2%), incomplete right bundle branch block (n = 8,
15.4%); left axis deviation (n = 1, 1.9%), right axis devi-
ation (n = 5, 9.6%), lateral early repolarization (n = 1,
1.9%) and inferior early repolarization (n = 3, 5.8%) (dis-
tinct from ‘repolarization abnormality’). Data from a
single-lead ECG during EEG-videotelemetry were available
for four patients. No supraventricular or ventricular ar-
rhythmias were detected, even during plegic episodes.
However, one patient with a normal resting 12-lead ECG
had dynamic J-point elevation in modiﬁed lead V1 on EEG-
videotelemetry recording (see below). Asystole was detected
in one patient by an implantable loop recorder, as previ-
ously reported. Figures 2–5 show illustrative segments from
abnormal ECGs.
The use of ﬂunarizine or not at the time of ECG was not
associated with ECG abnormalities (Fisher’s exact test,
Table 2 Summary of mutation status in ECG study
cohort
Nucleotide
change
Amino acid
change
Exon Number of
probands (%)
c.410C4T p.S137F 5 2 (3.8)
c.821T4A p.I274N 8 1 (1.9)
c.829G4A p.E277K 8 1 (1.9)
c.1010T4G p.L337R 9 1 (1.9)
c.2263G4A p.G755S 17 1 (1.9)
c.2314A4C p.S772R 17 1 (1.9)
c.2401G4A p.D801N 17 19 (36.5)
c.2411C4T p.T804I 17 1 (1.9)
c.2417T4G p.M806R 17 1 (1.9)
c.2431T4C p.S811P 18 1 (1.9)
c.2443G4A p.E815K 18 9 (17.3)
c.2755_2757delGTC p.V919del 20 1 (1.9)
c.2767G4T p.D923Y 20 1 (1.9)
c.2781C4T p.C927W 20 1 (1.9)
c.2839G4A p.G947R 21 6 (11.5)
No mutation 5 (9.6)
Total 52
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two-tailed, P = 1.0). The use or not of any antiepileptic
drug was not associated with ECG abnormalities (Fisher’s
exact test, two-tailed, P = 0.094).
Repolarization abnormalities
Repolarization abnormalities consisted of T wave inversion,
and/or abnormal T wave morphology. The average QTc
interval in all alternating hemiplegia patients was 394 ms
(range 350–440 ms). In the 52 disease controls, the mean
QTc was 418ms (range 380–460 ms, within the normal
range). Overall, the QTc interval was signiﬁcantly shorter
in the alternating hemiplegia cases compared with the dis-
ease control group (unpaired t-test, two-tailed,
P50.0001). Four patients (7.7%) had isolated inferior
repolarization abnormalities, two (3.8%) had isolated an-
terior repolarization abnormalities, three (5.8%) had
infero-lateral repolarization abnormalities, eight (15.4%)
had infero-anterior repolarization abnormalities and ﬁve
(9.6%) had widespread repolarization abnormalities in
the anterior, inferior and lateral leads (Table 3 and Fig. 2).
Intraventricular conduction delay
IVCD (n = 20) or incomplete right bundle branch block
(n = 10) were present in 28 individuals (53.8%), including
17 with concomitant repolarization abnormalities. Of the
26 patients with a normal resting 12-lead ECG, 10 (38.5%)
had IVCD in lead V1, and two (38%) had incomplete
right bundle branch block (Table 3 and Fig. 3). The preva-
lence of IVCD or right bundle branch block was signiﬁ-
cantly more common in alternating hemiplegia than in the
disease control cohort (28/52 versus 15/52; Fisher’s exact
test, two-tailed, P = 0.0164).
J wave changes
One patient (Patient 44) showed transient asymptomatic
cove-shaped ST segment elevation (J-point elevation), char-
acteristic of Brugada syndrome, on single-lead ECG record-
ing during EEG-videotelemetry (Fig. 4A and B). One
individual (Patient 21) had intermittent, dynamic 1 mm
J-point elevation in lead V1 (see below; Fig. 4E); a further
individual (Patient 18) had prominent notching of the ter-
minal portion of the QRS complex without J-point eleva-
tion (Fig. 4F) and four patients (Patients 9, 12, 14 and 40)
had early repolarization changes associated with repolari-
zation abnormalities (Fig. 4C and D).
Figure 2 Repolarization abnormalities. Examples of ECG
recordings showing widespread repolarization abnormalities in
Patient 5 (A), isolated inferior repolarization abnormalities in
Patient 23 (B), inferior and anterior repolarization abnormalities in
Patient 24 (C), and isolated anterior repolarization abnormalities in
Patient 47 (D).
Figure 3 Intraventricular conduction delay. Examples of
ECG recordings showing incomplete right bundle branch block
(RBBB) and anterior repolarization abnormalities in Patient 8 (A),
incomplete right bundle branch block in Patient 52 (B), IVCD and
anterior repolarization abnormalities in Patient 29 (inferior and
lateral repolarization abnormalities not shown) (C), and minor
IVCD in Patient 31 (D).
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Changes with age and related
to specific mutation
One individual (Patient 15) had a normal ECG with IVCD
at the age of 3 years; at age 9 years, incomplete right
bundle branch block and abnormal repolarization inferiorly
were noted (Fig. 5A and B). Dynamic changes were also
seen in Patient 7 (Fig. 5E and F). Overall, the prevalence of
ECG abnormalities was signiﬁcantly greater in individuals
aged5 16 years than in those5 16 years (P = 00095).
Nineteen patients harboured the p.D801N mutation: all
eight patients (421%)5 16 years, but only 6/11 patients
(188%)5 16 years, had abnormal ECGs (P = 0045).
The prevalence of any ECG abnormalities, and of repo-
larization abnormalities, remained signiﬁcantly higher in
the alternating hemiplegia cohort than in the disease con-
trol cohort if only the 47 cases with alternating hemiplegia
with ATP1A3 mutation were considered (P5 0.0001 for
both comparisons). The QTc interval also remained signiﬁ-
cantly shorter when comparing only the 47 alternating
hemiplegia cases with ATP1A3 mutation against all 52 dis-
ease controls (unpaired t-test, P5 0.0001).
Dynamic ECG changes
Three of ﬁve patients in whom serial 12-lead ECGs were
available had dynamic electrocardiographic changes that
varied from one ECG to another. Patient 9 had dynamic
T wave inversion in leads V1–V3 (Fig. 5C and D). Six
individuals (11.5%) had dynamic beat-to-beat ECG
changes: ﬁve had dynamic changes in the T wave morph-
ology (Fig. 5G), and one individual had intermittent 1 mm
J-point elevation in lead V1 (Fig. 4E).
Discussion
Alternating hemiplegia is a rare neurological disorder with
signiﬁcant phenotypic diversity (Panagiotakaki et al.,
2010). Known outcomes range from life into adulthood,
with comparatively little disability, to premature mortality
from sudden death. The broad range of presentations has
typically been ascribed to neurological abnormalities,
including epilepsy-related sudden death (SUDEP).
Discovery of the underlying cause of most cases, de novo
mutation in ATP1A3, is accelerating understanding of
Figure 4 J-point changes. Leads V1 and V2 of the normal baseline 12-lead ECG in Patient 44 (A). The same patient had a single lead (modified
V1) ECG recording during video-telemetry, showing dynamic features of Brugada syndrome. While the top tracing is normal, the bottom tracing,
recorded at a different time during the same recording, shows mild prolongation of QRS and J-point elevation (arrowheads) (B). Marked early
repolarization in inferior leads (arrowheads) in Patient 12 (C). Lateral early repolarization (arrowheads) in Patient 9 (inferior and anterior
repolarization abnormalities not shown) (D). Dynamic J-point elevation in V1 (arrowheads) in Patient 21 (E). Notching of the terminal portion of
QRS in V1 in Patient 18 (F).
ECG in alternating hemiplegia BRAIN 2015: 138; 2859–2874 | 2869
alternating hemiplegia (Heinzen et al., 2014). ATP1A3
expression extends beyond the brain, and includes the
heart (Aye et al., 2010). In keeping with this expression
pattern and both paroxysmal and interictal neurological
dysfunction in ATP1A3-related disease (Heinzen et al.,
2014), we show common and dynamic abnormalities of car-
diac physiology in alternating hemiplegia, as manifest in
electrocardiographic data. Our ﬁndings have implications
Figure 5 Age-related changes and dynamic changes. The baseline ECG performed in Patient 15 at the age of 3 years shows minor IVCD
(A). The ECG performed at the age of 9 years in the same subject shows incomplete right bundle branch block [inferior repolarization abnormalities
not shown (B)]. Dynamic anterior repolarization abnormalities in Patient 9: biphasic T-waves (arrowheads) in baseline ECG (C) and inverted T-waves
(arrowheads) in the ECG recorded a week later than the baseline ECG (D). The baseline ECG performed at the age of 18 years in Patient 7 shows
incomplete right bundle branch block, anterior repolarization abnormalities and right axis deviation [inferior repolarization abnormalities not shown
(E)]. The ECG performed at the age of 19 years in the same case shows IVCD and no anterior repolarization abnormalities [arrowheads (F)].
Inferior and lateral dynamic repolarization abnormalities with subtle beat-to-beat variation (arrowheads) in T-waves in Patient 10 (G).
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for the more complete understanding and management of
alternating hemiplegia, and other cardiocerebral disorders,
which include many epilepsies. The data also indicate the
need for caution with drugs used for other symptoms or
problems in people with alternating hemiplegia, as is the
case, for example, with Brugada syndrome.
Overall, we show some type of ECG abnormality in just
over half the cases (28/52). These abnormalities fall into
three main categories: abnormal repolarization, with or
without IVCD or incomplete right bundle branch block;
J-wave or J-point changes; and the previously-reported
single case of asystole. Repolarization abnormalities were
present in 25 patients (48.1%), whereas they are seen in
only 2% of healthy adults (Rautaharju et al., 2009). While
isolated IVCD and incomplete right bundle branch block
changes can be normal ﬁndings, the prevalence in our
cohort (21.2%) is much higher than published normal
data [2.3% in females; 4.7% in males (Bussink et al.,
2013)], particularly in children [1% (Chiu et al.,
2008)], and much higher than the prevalence in disease
controls with epilepsy. In addition, corrected QT intervals
were signiﬁcantly shorter in the alternating hemiplegia
cohort compared to epilepsy disease controls. Short QT
syndrome is a relatively recently-described cardiac channe-
lopathy associated with a high risk of ventricular arrhyth-
mia and sudden death (Priori et al., 2013), and mutations
in KCNJ2 have recently been reported in patients with
short QT syndrome and an autism–epilepsy phenotype
(Ambrosini et al., 2014). In contrast, QT prolongation
(rather than shortening) has been reported in individuals
with epilepsy (Surges et al., 2010), suggesting that if alter-
nating hemiplegia has an effect on the QT interval, it is the
opposite of that seen in people with epilepsy. These ﬁndings
are intriguing, but will require more data, possibly includ-
ing longitudinal data, to interpret.
Several of the characteristics of the changes observed are
typical of inherited cardiac channelopathies: the waveforms
themselves, emergence with age, and beat-to-beat or ECG-
to-ECG variation. In one case, a transient waveform was
typical of that seen in Brugada syndrome, an inherited car-
diac electrophysiological disorder most commonly asso-
ciated with loss-of-function mutations in the cardiac
sodium channel gene SCN5A (in 20–30% of cases; Priori
et al., 2013). Dynamic ECG changes are known to occur in
many genetic cardiac channelopathies. A study of 89 pa-
tients with Brugada syndrome who underwent implantable
cardiovertor deﬁbrillator insertion and had serial ECG
recordings revealed that only 24% of all ECGs per patient
showed the diagnostic coved-type ST-segment elevation,
25% showed non-diagnostic ST-segment changes, and
51% were normal (Richter et al., 2009). Studies of serial
ECGs in patients with long QT syndrome revealed consid-
erable variability in QTc interval duration, with some
measurements falling within the normal range
(Goldenberg et al., 2006; Lee et al., 2013). The observed
transience of the abnormalities recorded in our cohort sug-
gests our ﬁndings, based largely on standard brief interictal
ECG records, may underestimate the true prevalence of
ECG abnormalities in alternating hemiplegia, and point to
the need for systematic studies with longer ECG recordings.
ECG abnormalities were more common in patients
16 years or older compared with those under 16. The
p.D801N, p.E815K and p.G947R mutations are the most
common mutations reported; p.E815K is generally asso-
ciated with the most severe course of disease (Sasaki
et al., 2014). In our cohort of patients, the most frequent
mutation identiﬁed was pD801N (36.5%), followed by
c.2443G4A; p.E815K (17.3%), and c.2839G4A;
p.G947K (11.5%), consistent with published data.
Overall, 73.7% of those harbouring D801N mutations
had abnormal ECG recordings; 57% of those with
abnormalities were aged over 16 (Table 3). Age-related
penetrance of cardiac conduction abnormalities has been
described in other cardiac channelopathies. In SCN5A
mutation-positive patients with Brugada syndrome, intra-
ventricular conduction changes were found to progress
with age (Probst et al., 2006; Veltmann et al., 2006). In
a large Portuguese family with Brugada syndrome, all 43
family members under age 16 had normal ECGs (Santos
et al., 2010). Our relatively small case numbers make other
genotype–phenotype or age-related analyses less meaning-
ful, but overall the observations are in keeping with age-
related penetrance seen in known inherited cardiac
channelopathies.
The Na+ /K+ -ATPase transporter is critical in main-
taining electrochemical gradients across cell membranes
by coupling hydrolysis of ATP with transmembrane
3Na+ /2K+ exchange. The catalytic -subunit in humans
has four isoforms: 1, 2, 3 and 4 encoded by
ATP1A1, ATP1A2, ATP1A3 and ATP1A4, respectively,
with differential tissue expression. Isoforms 1, 2, and 3
are expressed in the CNS; 1 ubiquitously, 2 predomin-
antly in astrocytes and 3 in peripheral and central neu-
rons; all three isoforms are expressed in healthy human
cardiomyocytes with variable mRNA levels of each subunit;
63% (1), 15% (2) and 23% (3) (Zahler et al., 1993).
Models of alternating hemiplegia [Myshkin mouse model
(Kirshenbaum et al., 2013); Drosophila (Ashmore et al.,
2009)], together with comparative molecular modelling,
have demonstrated that some causal mutations in alternat-
ing hemiplegia (p.D801N, p.I274N, p.I810S, p.D923Y)
lead to signiﬁcant structural changes of the ATPase protein,
affecting potassium binding and conductance (Ashmore
et al., 2009; Kirshenbaum et al., 2013). In vitro studies
show that p.E815K, p.I274N and p.G947R mutants have
loss of ATPase activity and do not bind the ATPase inhibi-
tor, ouabain, compatible with complete loss of function,
whereas D801N mutants show absent ATPase activity,
but retained ouabain-binding function, indicating abnormal
cation binding and reduced K+ afﬁnity, lending support to
the correlation between E815K and a more severe pheno-
type (Weigand et al., 2014). The underlying basis of the
ECG abnormalities observed is not yet explained, but the
ﬁndings point to dynamic abnormality of cardiac
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repolarization reserve. This ‘reserve’ is the physiological re-
dundancy of capacity to repolarize the myocardium that is
the result of the multiple inward and outward cardiomyo-
cyte currents that inﬂuence repolarization (Roden, 1998).
Impaired repolarization reserve is considered important in
sudden death associated with inherited cardiac channelopa-
thies, and may possibly have a role in SUDEP.
Our ﬁndings suggest that alternating hemiplegia can be
considered another cardiocerebral disorder, and that car-
diac evaluation, with at least ECG, should be considered
in alternating hemiplegia, especially in older (516 years)
patients. Our data do not permit more speciﬁc recommen-
dations, but we note that in some cases, dynamic ECG
changes of importance were only seen brieﬂy during pro-
longed recording. The dynamic nature of ECG changes is
reﬂected in the dynamic nature of many neurological symp-
toms that is typical of alternating hemiplegia, and may
share a mechanistic explanation, though we note that
there is obviously no link between the actual timing of
ECG and neurological changes. The absence of ECG
changes during a seizure or plegic episode does not pre-
clude the existence of ECG changes at other times in the
same individual.
We note that the general concept of ‘cardiocerebral chan-
nelopathy’ is further underpinned by several recent reports
of cardiac arrhythmia, such as long QT syndrome or
Brugada syndrome, in single individuals or kindreds with
epilepsy due to mutations in ion channel genes such as
KCNH2 (Johnson et al., 2009; Omichi et al., 2010;
Zamorano-Leo´n et al., 2012; Partemi et al., 2013) and
KCNQ1 (Goldman et al., 2009; de Llano et al., 2015).
Our study has limitations. These include limited sampling
of the ECG, leading to possible underestimates of the
prevalence of abnormalities; possible referral bias, as invi-
tation to participate followed the publication of a single
case report (Novy et al., 2014), though it should be
noted that the ﬁndings in that case were not typical of
those reported here; ascertainment bias is also likely, as
patients with alternating hemiplegia who may have been
undiagnosed and died early would not have been included,
again leading to underestimation of prevalence of abnorm-
alities; and the lack of other functional cardiac data, includ-
ing echocardiography and measures of cardiac function.
ECGs were not reviewed in blinded fashion. Although
older patients were more likely to be taking antiepileptic
drugs, we show that the use of ﬂunarizine or antiepileptic
drugs was not associated with whether a patient had ECG
abnormalities or not. Overall, the spectrum of drugs taken
is not associated with repolarization abnormalities: interval
prolongation (e.g. affecting QTc) and arrhythmias seen
with antiepileptic drugs (Surges et al., 2010) were not
observed in our sample, while ﬂunarizine has no effect on
normal dog heart (Vos et al., 1992). We did not include
normal controls, as the waveforms and parameters studied
have well-established normal ranges from thousands of in-
dividuals (e.g. Rautaharju et al., 2009; Surawicz et al.,
2009). The number of cases (ﬁve) without ATP1A3
mutation was small: none of these cases had documented
ECG changes. Comparisons between alternating hemiplegia
cases and the disease control group remained signiﬁcant
when considering only the ATP1A3 mutation-bearing alter-
nating hemiplegia cases.
Three-quarters of our cases had had seizures or had a
diagnosis of epilepsy (Table 1 and Supplementary
Table 1). ECG abnormalities are recognized, and probably
under-reported, in epilepsy (Lamberts et al., 2015). Our
ﬁndings might be considered to reﬂect the seizure disorders
in our patients with epilepsy, but we show that the preva-
lence both of any abnormality and of repolarization
abnormalities is signiﬁcantly higher in the alternating hemi-
plegia cases than in an age-matched disease control cohort
of people with epilepsy. Moreover, not all patients with
ECG abnormalities had epilepsy, and our ﬁndings illustrate
that in alternating hemiplegia, somatic (cardiac) co-
morbidity is not temporally related to plegic episodes or
seizures, but probably due to shared expression in heart
and brain of mutated protein. In a knock-in mouse model
of alternating hemiplegia, with the D801N mutation, there
is a higher incidence of sudden death than expected: some
mice had witnessed seizure-related death, considered to be
SUDEP, but there were also mice ‘found dead’ and others
who died ‘spontaneously’ (Hunanyan et al., 2015). Sudden
premature death in alternating hemiplegia is not always
explained. It has been ascribed to cardiorespiratory dys-
function, for which our ﬁndings provide a further basis.
Our ﬁndings may have broader application to the concept
of independent cardiac dysfunction as a mechanism for
some cases of sudden death in epilepsy (Parisi et al.,
2013), especially with increasing numbers of channels and
channel-related pathways being causally implicated in epi-
lepsy. Systematic evaluation of function in organs sharing
expression of mutated genes needs consideration with any
newly-discovered genetic cause of a condition. In alternat-
ing hemiplegia, study of other systems that express
ATP1A3 should also be considered. Systematic longitudinal
cardiac studies are also now necessary in alternating hemi-
plegia, as cardiac arrhythmic death is potentially
preventable.
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